| The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women JA Kanis, A Odén, O Johnell, H Johansson, C De Laet, J Brown, ... Osteoporosis international 18 (8), 1033-1046, 2007 | 1233 | 2007 |
| Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo … RECORD Trial Group The Lancet 365 (9471), 1621-1628, 2005 | 1138 | 2005 |
| Guidelines for diagnosis and management of osteoporosis JA Kanis, P Delmas, P Burckhardt, C Cooper, D Torgerson Osteoporosis international 7 (4), 390-406, 1997 | 1002 | 1997 |
| Understanding controlled trials: What are pragmatic trials? M Roland, DJ Torgerson Bmj 316 (7127), 285, 1998 | 816 | 1998 |
| Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials DJ Torgerson, SEM Bell-Syer Jama 285 (22), 2891-2897, 2001 | 698 | 2001 |
| Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care J Porthouse, S Cockayne, C King, L Saxon, E Steele, T Aspray, ... Bmj 330 (7498), 1003, 2005 | 676 | 2005 |
| United Kingdom back pain exercise and manipulation (UK BEAM) randomised trial: effectiveness of physical treatments for back pain in primary care UK Beam Trial Team Bmj 329 (7479), 1377, 2004 | 605 | 2004 |
| Randomised controlled trial of exercise for low back pain: clinical outcomes, costs, and preferences JK Moffett, D Torgerson, S Bell-Syer, D Jackson, H Llewlyn-Phillips, ... Bmj 319 (7205), 279-283, 1999 | 514 | 1999 |
| Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials S Cockayne, J Adamson, S Lanham-New, MJ Shearer, S Gilbody, ... Archives of internal medicine 166 (12), 1256-1261, 2006 | 503 | 2006 |
| Contamination in trials: is cluster randomisation the answer? DJ Torgerson Bmj 322 (7282), 355-357, 2001 | 460 | 2001 |
| Should we pay the patient? Review of financial incentives to enhance patient compliance A Giuffrida, DJ Torgerson Bmj 315 (7110), 703-707, 1997 | 455 | 1997 |
| A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update R Eastell, DM Reid, J Compston, C Cooper, I Fogelman, RM Francis, ... Journal of internal medicine 244 (4), 271-292, 1998 | 452 | 1998 |
| Designing randomised trials in health, education and the social sciences: an introduction D Torgerson Springer, 2008 | 446 | 2008 |
| Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design C Relton, D Torgerson, A O’Cathain, J Nicholl Bmj 340, 2010 | 419 | 2010 |
| Understanding controlled trials. What is a patient preference trial? DJ Torgerson, B Sibbald BMJ: British Medical Journal 316 (7128), 360, 1998 | 403* | 1998 |
| Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group The BMJ 340, 2010 | 394 | 2010 |
| General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial GTC Group The Lancet 372 (9656), 2132-2142, 2008 | 392 | 2008 |
| Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation ND Mdege, MS Man, CA Taylor, DJ Torgerson Journal of clinical epidemiology 64 (9), 936-948, 2011 | 374 | 2011 |
| Definitions of efficiency S Palmer, DJ Torgerson Bmj 318 (7191), 1136, 1999 | 371 | 1999 |
| Cost of illness studies S Byford, DJ Torgerson, J Raftery Bmj 320 (7245), 1335, 2000 | 368 | 2000 |
